chrX-130129579-A-T
Variant summary
Our verdict is Likely benign. Variant got -3 ACMG points: 1P and 4B. PP3BS2
The NM_004208.4(AIFM1):c.1820T>A(p.Leu607Gln) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000108 in 1,209,153 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 5 hemizygotes in GnomAD. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Synonymous variant affecting the same amino acid position (i.e. L607L) has been classified as Likely benign.
Frequency
Consequence
NM_004208.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
AIFM1 | NM_004208.4 | c.1820T>A | p.Leu607Gln | missense_variant | 16/16 | ENST00000287295.8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
AIFM1 | ENST00000287295.8 | c.1820T>A | p.Leu607Gln | missense_variant | 16/16 | 1 | NM_004208.4 |
Frequencies
GnomAD3 genomes AF: 0.0000269 AC: 3AN: 111499Hom.: 0 Cov.: 22 AF XY: 0.00 AC XY: 0AN XY: 33683
GnomAD3 exomes AF: 0.00000545 AC: 1AN: 183490Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 67920
GnomAD4 exome AF: 0.00000911 AC: 10AN: 1097654Hom.: 0 Cov.: 29 AF XY: 0.0000138 AC XY: 5AN XY: 363022
GnomAD4 genome AF: 0.0000269 AC: 3AN: 111499Hom.: 0 Cov.: 22 AF XY: 0.00 AC XY: 0AN XY: 33683
ClinVar
Submissions by phenotype
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Mayo Clinic Laboratories, Mayo Clinic | Nov 22, 2022 | PP3 - |
Combined oxidative phosphorylation deficiency;CN118851:Charcot-Marie-Tooth Neuropathy X Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Invitae | Nov 17, 2022 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on AIFM1 protein function. This variant has not been reported in the literature in individuals affected with AIFM1-related conditions. This variant is present in population databases (no rsID available, gnomAD 0.03%). This sequence change replaces leucine, which is neutral and non-polar, with glutamine, which is neutral and polar, at codon 607 of the AIFM1 protein (p.Leu607Gln). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at